Permira to fund TBS buyout via levloan market in rude health
Pantheon Healthcare, the pharmaceutical developer owned by Permira, is marketing a €300m loan to finance the acquisition of Telematic and Biomedical Services with bankers saying demand for leveraged loans shows no signs of abating.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: